GEA's wide range of container blenders offers the most flexible and highest quality blending solutions available today.
Container blending is recognised as being the most cost-effective and productive method of blending granules and powders in the pharmaceutical manufacturing process. Reduced loading and unloading times, reduced cleaning times — both machinery and room — improved containment and batch integrity have established container (IBC) blending as the pharmaceutical industry’s technology of choice.
R&D, small-scale and full-scale pharmaceutical production blenders provide simple transfer of process technology during scale-up, thus minimizing process validation activity.
This is fully supported by GEA's detailed research programme and testing facilities. Hoist- and pedestal-mounted versions are available as well as through-the-wall designs, which offer significant room layout benefits.
Ports now compete not just on logistics, but on sustainability. At Greece’s Piraeus port, an advanced processing and recovery facility recycles ship waste oil into fuel. Equipped with GEA’s high-performance centrifuges, it sets a new benchmark for state-of-the-art, environmentally responsible port operations.
The 2022 CO2 shortage forced breweries to review their dependency on global supply chains. Many were forced to close, unable to carbonate their products. At its breweries in Germany, OeTTINGER GETRÄNKE is turning its own CO2 into a powerful lever for independence and sustainability – with the help of CO2 recovery technology from GEA.
In a shifting political and economic landscape, GEA stays the course. We spoke with Dr. Nadine Sterley, GEA’s Chief Sustainability Officer, about why sustainability remains central to the company’s business strategy, how GEA is progressing on its ambitious goals and what it takes to turn words into action.